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Objective. There are conflicting views on time trends of asthma and atopy during the last 10–15
years. Additional confusion is caused by the term of asthma which is a unifying name for differ-
ent phenotypes. Asthma has been a topic for investigation to the Swiss Sentinel Surveillance
Network (SSSN) since 1989. The objective of the actual study was to determine the influence
of the allergic and non-allergic components of asthma on time trends from 1999 to 2005.
Methods. Primary care physicians participating in the SSSN were guided by diagnostic criteria
for asthma. Rates of asthma episodes per 1000 consultations were calculated for all, for first and
subsequent asthma episodes and for allergic and non-allergic asthma. Allergic asthma was de-
fined as asthmatic manifestations in conjunction with eczema and/or hay fever. The smoothed
time trend and its 95% confidence intervals were determined using generalized additive models
with a loess smoother adjusting for seasonality.
Results. Consultations for allergic asthma have decreased between 1999 and 2005. Looking at
different age groups, asthma associated with hay fever was reported with decreasing frequency
in all age groups, whereas when associated with eczema, the other used marker of allergic
asthma, slightly increased among young children.
Conclusions. The decrease of consultations for asthma is most probably due to the allergic
component of asthma. Diagnostic shift over time and ready available medications probably con-
tributed to this phenomenon. Our findings indicate a real decline of allergic asthma.
Practice recommendations. Consultations for asthma have decreased over recent years. The
decrease of consultations for asthma is most probably due to the allergic component of asthma.
Diagnostic shift over time and available medications probably contributed to this phenomenon.
Strength of Recommendation Taxonomy (SORT) rating: strength of recommendation = C, level
of evidence = 3.
Keywords. Allergic asthma, non-allergic asthma, time trends, primary health care.
Introduction
A broad consensus exists that the prevalence of
asthma has increased during the 1970s and 1980s,1 as
well as that of other atopic diseases such as allergic rhi-
nitis and eczema.2,3 However, there are conflicting
views on time trends of asthma and atopy during the
last 10–15 years. Different methods of epidemiological
investigation, regional characteristics and health care
have been brought forward to explain this discrepancy.
Results from the International Study of Asthma and
Allergies in Childhood (ISAAC) have shown not only a
rise in prevalence of asthma, allergic rhinoconjunctivitis
and eczema symptoms in many centres but also the ab-
sence of increases in prevalence of asthma symptoms for
centres with existing high prevalence in the older age
group.4 Additional confusion is caused by the term
‘asthma’. Asthma encompasses a disparate group of dis-
orders which produce variable airflow obstruction, a more
recent concept that has been disregarded in most studies.5
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Asthma has been a topic for investigation by the
Swiss Sentinel Surveillance Network (SSSN) since
1989. The seasonal patterns of asthma have been de-
scribed6,7 and practice incidence has been studied.8
Additional information on consultations for allergic
and non-allergic asthma on the basis of the association
of asthma with eczema and hay fever has been gath-
ered since 1999.
The objective of this work was to explore which
phenotype of asthma, allergic or non-allergic, contrib-
uted to the decline of consultations for asthma in pri-
mary care practices in Switzerland. Allergic asthma
was defined as asthma associated with hay fever and/
or eczema.
Methods
The Swiss Sentinel Surveillance Network
The SSSN, a monitoring system for infectious diseases
and health problems which are important and/or fre-
quent in primary health care, has been operating since
1986.9 Sampling of participating physicians is based on
stratification by geographic area, socio-demographic
characteristics and their speciality.10 Primary care in
Switzerland is delivered mainly by GPs, general intern-
ists and paediatricians, a proportion of whom partici-
pate voluntarily in the SSSN. Based on the adjusted
total number of consultations and home visits, the par-
ticipants cover more than 3% of all consultations and
count for about 3% of primary care physicians in the
country. To ensure consistency, this study included
data from 90% of the reporting physicians who re-
ported >75% of the time. The Swiss Health Care Sys-
tem is non-centralized and patients are free to attend
a doctor of their choice except if in managed care.
Asthma
The definition of asthma in the SSSN includes exer-
tional, allergic and infectious causes: bronchial ob-
struction or hyperresponsiveness diagnosed by the
presence of wheezing, dyspnoea or cough during or af-
ter physical exertion or on contact with pollen, dust or
animal dander and cough at night without an acute re-
spiratory infection or for more than 2 weeks after an
acute respiratory infection.11 Allergic asthma episodes
were defined as episodes in patients suffering from ec-
zema and/or hay fever.12
The number of first and subsequent consultations
for asthma and its association with eczema and/or hay
fever has been recorded since 1999 in order to discern
allergic from non-allergic asthma. Patients’ age and
sex were also recorded.
Statistical analysis
Monthly and yearly rates of episodes per 1000 consul-
tations were calculated from weekly reports for the
period 1999–2005. Annual rates were determined for
first and subsequent asthma episodes, for allergic and
non-allergic asthma and for the respective subgroups of
allergic asthma. Comparisons of annual mean rates
were performed using the Mann–Whitney U test. The
average trend of the number of asthma consultations
was computed using generalized linear models with an
approximated Poisson distribution (binomial distribu-
tion from a large sample of consultations and a small
probability of asthma episodes). These regression mod-
els contained a linear (and when relevant, a quadratic)
trend variable accounting for secular trends in consulta-
tion rates and a season variable to control for repeat-
able fluctuations over time. The SAS software13 was
used for the calculation of rates and regression models.
The change of rates with time is represented graphi-
cally. First, the observed rates and then the smoothed
long-term time trend are plotted. The smoothed time
trend and its 95% confidence interval (CI) were deter-
mined using generalized additive models with a loess
smoother adjusting for seasonality and a smoothing
span of 0.67. These models were calculated using
S-PLUS.14 Smoothing is a data analysis technique for
making the general shape of a time series apparent.
Results
Table 1 summarizes the relation between participants
in the SSSN and consultations for asthma. The mix of
primary care physicians was quite stable, averaging
58.5% (range: 56.3–59.8) for GPs, 27.4% (range: 25.8–
28.6) for general internists and 14.1% (range: 12.1–
16.3) for paediatricians. The age distribution among
patients did not change over time (data not shown).
Consultation rates for all, for first and subsequent epi-
sodes of asthma decreased between 1999 and 2005
with the strongest decline in earlier years.
Figure 1(a) shows the change of asthma phenotype
episodes per 1000 consultations with time. The rate of
allergic asthma showed a decrease of 0.15% per week
(P = 0.0140), i.e. 7.5% per year. The decrease in rate
of non-allergic asthma (0.08% per week or 4.1% per
year) was statistically non-significant (P = 0.1188).
Peaks for allergic and non-allergic asthma occur at en-
tirely different periods of a year. To determine if a dis-
tinction between allergic and non-allergic asthma is
recognizable in routine recording, the trend in rates
was examined only during a typical hay fever season
(May to August). The rate of allergic asthma episodes
decreased 9.1% per year (P = 0.0477) and that for
non-allergic asthma 2.2% per year (P = 0.6693). All
trends were linear. Figure 1(b) focuses on time trends
of allergic and non-allergic asthma among 0- to 16-
year-old children per 1000 paediatric consultations.
Trends are similar to those in Figure 1(a).
Figure 2 shows, for different age groups, the
curves for eczema-related and hay fever-related
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asthma consultations. Hay fever (30–44%) was re-
ported more often in conjunction with asthma than
eczema (10–13%). Asthma in children 0–4 years of
age suffering from eczema showed an average in-
crease of 9.4% per year from a mean of 142 episodes
per 1000 asthma episodes (95% CI: 103–181) in 1999
to 238 episodes per 1000 asthma episodes (95% CI:
154–322) in 2005, P = 0.0939 (Mann–Whitney U-
test). Asthma in patients suffering from hay fever
showed a decrease in all age groups. In 0–4 years
old, the decrease was 24.4% per year from 255 (95%
CI: 175–335) to 96 (95% CI: 38–155), P = 0.0045, in
5–16 years old 4.7% per year from 556 (95% CI:
471–640) to 433 (95% CI: 302–565), P = 0.1020 and
in all ages together 6.2% per year from 400 (95%
CI: 359–442) to 263 (95% CI: 220–306), P = <0.0001,
between 1999 and 2005. The average rates above
were calculated using a linear and quadratic term
for time.
First and subsequent asthma consultations showed
similar size effects for the change of both asthma phe-
notypes with time.
Discussion
The consultations for asthma have decreased over time
mainly due to a decrease of allergic asthma. Consulta-
tions for non-allergic asthma did not change signifi-
cantly between 1999 and 2005. Whereas eczema
associated with asthma seems to have slightly in-
creased over recent years among young children, hay
fever associated with asthma was reported with de-
creasing frequency from 1999 to 2005 in all age groups.
Limitations
Our findings have to be interpreted in light of several
characteristics of the SSSN. First, the incidence/
TABLE 1 Participants and consultations for asthma in the SSSN, 1999—2005a
1999 2000 2001 2002 2003 2004 2005
Total SSSN participantsb
n 231 240 224 223 224 217 194
% of all primary care physicians in Switzerland 3.0 3.1 3.0 3.4 3.0 2.9 2.6
GPs
n 130 139 134 132 134 125 115
% 56.3 57.9 59.8 59.2 59.8 57.6 59.3
General internists
n 66 62 60 60 63 62 52
% 28.6 25.8 26.8 26.9 28.1 28.6 26.8
Paediatricians
n 35 39 30 31 27 30 27
% 15.2 16.3 13.4 13.9 12.1 13.8 13.9
Total SSSN consultationsc
n 1 060 644 1 129 277 1 022 771 986 958 991 816 948 105 843 172
% of all primary care consultations in Switzerland 4.0 4.2 3.9 3.8 3.9 3.6 3.1
Consultations for asthma
n 2336 2346 1720 1632 1549 1604 1324
Rate per 1000 consultations 2.20 2.08 1.68 1.65 1.56 1.69 1.59
First asthma episodes
n 818 845 601 671 556 576 468
Rate per 1000 consultations 0.77 0.75 0.59 0.68 0.56 0.61 0.56
Subsequent asthma episodes
n 1518 1501 1119 961 993 1028 874
Rate per 1000 consultations 1.43 1.32 1.09 0.97 1.00 1.08 1.04
Hay fever-related asthma
n 1030 962 610 486 595 531 404
Rate per 1000 consultations 0.98 0.85 0.60 0.49 0.56 0.56 0.48
Eczema-related asthma
n 241 267 231 192 208 178 162
Rate per 1000 consultations 0.23 0.24 0.23 0.19 0.21 0.19 0.19
Allergic asthma consultations (hay fever and/or eczema related)
n 1035 962 707 581 676 632 500
Rate per 1000 consultations 0.98 0.85 0.69 0.59 0.68 0.67 0.59
Non-allergic asthma consult
n 1310 1392 1013 1051 873 972 842
Rate per 1000 consultations 1.23 1.23 0.99 1.06 0.88 1.03 1.00
aSome of the counts and rates from 1999 to 2001 were reported in ref. 8.
bEligible for evaluation, i.e. reporting for at least 39 weeks per year.
cBased on the data pool by sante´suisse, the state subsidized insurance company from all sickness funds.
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prevalence of asthma in the SSSN is not based on pop-
ulations but on consultations as there is no patient’s
list system in Switzerland. Second, exact age-specific
distributions could not be computed as age and sex
were collected only for consultations for asthma, but
not for the total number of consultations. However,
by extrapolation from a two times 2 weeks’ registra-
tion of age and sex for every consultation in each year
(in May and October), it could be ascertained that the
age distribution did not change in spite of somewhat
changing proportions within primary care physicians
in the SSSN. We also accounted for the lack of precise
age-specific distribution by referring to age-independent
parameters. Third, the physicians’ diagnoses have not
been validated by objective measures such as skin
prick tests, serological tests to determine specific IgE
levels or pulmonary function tests. However, self-
reported physician’s diagnosis of asthma among adults
and children has been shown to be fairly specific15,16
and SSSN physicians were guided by precise diagnos-
tic criteria, which remained unchanged throughout the
study period.11
Phenotypic categories
Inconsistent findings from incidence studies on asthma
may be due to the fact that allergic and non-allergic
asthma have not been distinguished from each other
in epidemiological studies. Asthma is not a single
disease entity. Viral wheeze or transient wheeze is
a non-atopic disorder with risk factors and prognosis
that differ from the atopy-related wheeze phenotypes
which are typical of late onset or persistent asthma in
schoolchildren.17 Similarly, viruses can cause broncho-
constrictive symptoms and signs such as cough and dif-
ficult breathing in adults.18
In this study, we divided asthma into two broad cat-
egories, allergic and non-allergic asthma. The highly
discordant peaks between allergic and non-allergic oc-
currence lines (see Figure 1) reveal the presence of
two different entities of asthma and underscore the as-
sumption that participants in the SSSN can discrimi-
nate well between wheezing and cough triggered by
respiratory infection and/or exercise and allergen-
driven episodes of bronchoconstrictive manifestations.
FIGURE 1 Long-term trends of allergic and non-allergic
asthma: (a) episodes per 1000 consultations in all age group
and (b) episodes per 1000 consultations by paediatricians in
0–16 years old
FIGURE 2 Association of asthma with eczema and hay fever:
(a) 0–4 years old, (b) 5–16 years old and (c) all ages
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The separate analysis of allergic and non-allergic
asthma among 0- to 16-year-old children (making up
for 76% of all asthma consultations), seen by paedia-
tricians in the SSSN (98% of all patients seen by pae-
diatricians were in the age range of 0–16), resulted in
the same trends for the two phenotypes. This is
in agreement with the notion that allergic and non-
allergic asthma exist in all age groups19,20 and that
asthma takes its biggest share among children. Typi-
cally, viral-induced episodic asthma is more frequent
among children than in the all ages group.
Asthma, eczema and allergic rhinitis
Older children and adults experience more asthmatic
episodes in May, June and July, an observation which
probably reflects the association of hay fever with
asthma.6,7,21 Children with eczema are at high risk of
allergic asthma and allergic rhinitis22. A link between
allergic rhinitis and asthma is evident from epidemio-
logical, pathophysiological and clinical studies.23 In
a primary care-based survey of patients with asthma,
76% of patients with asthma reported symptoms indic-
ative of allergic rhinitis24. Based on studies about the
relation between asthma and allergic rhinitis, it has
even been suggested that asthma and allergic rhinitis
should always be considered together in diagnosis and
management.25
In the present study, the two markers of allergy, ec-
zema and hay fever, were used to define allergic
asthma. Other markers such as food allergy or anaphy-
laxis were not taken into consideration as diagnosis is
often uncertain for the former and as they are rare.
Non-allergic asthma comprised all other consultations
for asthma. We found that eczema showed an incon-
sistent pattern, increasing among small children and
remaining stable among older children and adults,
and that hay fever in association with asthma declined
between 1999 and 2005. The non-allergic component
of asthma did not change in relation to the allergic
component. Our findings are in accordance with time
trends of allergic disorders in the UK where the preva-
lence and health care usage for eczema and hay fever
was found to have stabilized or even fallen in recent
years.26 Similar findings came off from a review on
asthma over the last 50 years in the UK, showing evi-
dence that trends flattened or even began to fall in
the late 1990s and early 2000s.27 The rise in prevalence
of asthma, allergic rhinoconjunctivitis and eczema
symptoms reported in the ISAAC4 has come to a still
stand as shown by some centres having completed
Phase III of that study.28,29 Our enquiry whether the
decline of consultations for asthma in primary care
might be linked to there increase with specialists was
unproductive as there is no monitoring of such data in
the secondary care sector of Switzerland.
A possible explanation for our findings is that the
reporting of increasing prevalence rates of asthma in
the last decades caused an increased awareness among
the general public as well as physicians, which in turn
interfered with the diagnostic classification.30 Before
the 1980s, wheezy children were referred to as
‘wheezy bronchitis’.31 Most of these children stop
wheezing at school age. Including them under the uni-
fying name of asthma is incompatible with diagnostic
accuracy.
The increased use of medications, especially in-
haled steroids and beta-agonists in symptomatic sub-
jects, may have led to better asthma control and
a decreased health care usage by asthmatic patients.
The decrease of hay fever in asthmatic patients may
also be explained by ready available treatment by pa-
tients with antihistaminic tablets and nasal cortico-
steroid sprays. Prescription of corticosteroid drugs
and bronchodilators in the UK had risen steadily
since the early 1970s and prescriptions for both of
these categories have levelled off since the late
1990s.27 In Switzerland, the moving annual total of
prescriptions for corticosteroids and bronchodilators,
either as a single or as a combined drug, and anticho-
linergic and antihistaminic drugs as well as leukotri-
ene antagonists, for the two diagnoses of bronchial
asthma and obstructive lung disease, shows a 10–15%
fall since 2001 (IMS Health, personal communication).
While these sales’ characteristics could explain the con-
sultation recession for asthma, they cannot explain
why the tide of asthma has remained low although
medication prescriptions fell at the same time. Might it
be that allergic disorders have truly declined in recent
years?
Conclusions
Consultations for asthma and hay fever-related asthma
in the primary care setting of Switzerland have de-
creased over time. The clinical distinction between al-
lergic and non-allergic asthma on the basis of the
association of asthma with eczema and/or hay fever
shows that, most probably, it is the allergic component
of asthma which has contributed to this fall. Different
coding of asthma with time, therapeutic advances and
changes in the health care pattern and usage must be
considered as confounding variables in the epidemio-
logical picture of asthma.
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